ガイドライン

有効性評価に基づく大腸がん検診ガイドライン
平成16年度 厚生労働省がん研究助成金
「がん検診の適切な方法とその評価法の確立に関する研究」班

書誌情報
文献

 
1) 大島明,黒石哲生,田島和雄編著.がん・統計白書 ―罹患/死亡/予後―2004.2004.篠原出版.東京.
2) 武藤徹一郎. 大腸ポリープ・ポリポーシス. 1993. 医学書院.東京.
3) Stryker SJ, Wolff BG, Culp CE, Libbe SD, Ilstrup DM, MacCarty RL. Natural history of untreated colonic polyps. Gastroenterology. 1987;93(5):1009-13.
4) World Cancer Research Fund/ American Institute for Cancer Research: Food, nutrition and prevention of cancer: a global perspective. American Institute for Cancer Research, Washington DC, 1997.
5) 日本がん疫学研究会がん予防指針検討委員会: 生活習慣と主要部位のがん.1998.九州大 学出版会.福岡.
6) Food, nutrition and the prevention of chronic diseases. - WHO technical report series 916: Report of a joint WHO/FAO expert consultation - Geneva: WHO; 2003.
7) 平成12年度厚生労働省老人保健事業推進費等補助金 がん検診の適正化に関する調査 研究事業 新たながん検診手法の有効性評価報告書(主任研究者 久道茂).2001.公衆衛生協会
8) Harris RP, Helfand M, Woolf SH, Lohr KN, Mulrow CD, Teutsch SM, Atkins D, et al. Current methods of the US Preventive Services Task Force: a review of the process. Am J Prev Med.2001;20(3Suppl):21-35.
9) Pignone M, Rich M, Teutsch SM, Berg AO, Lohr KN. Screening for colorectal cancer in adults at average risk: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2002;137(2):132-41.
10) Smith RA, Cokkinides V, Eyre HJ,et al. American Cancer Society Guidelines for the early detection of cancer, 2003.CA Cancer J Clin: 2003;53(1):27-43.
11) Rex DK, Johnson DA, Lieberman DA, Burt RW, sonnenberg A. Colorectal cancer prevention 2000: Screening recommendations of the American College of Gastroenterology. American College of Gastroenterology. Am J Gastroenterol. 2000;95(4):868-77.
12) Winawer S, Fletcher R, Rex D, Bond J, Burt R, Ferrucci J, Ganiats T, Levin T, Woolf S, Johnson D, Kirk L, Litin S, Simmang C, et al. Colorectal cancer screening and surveillance: clinical guideline and rationale- update based on new evidence. Gastroenterology. 2003;124:544-60.
13) Simmang CL, Senatore P, Lowry A, Hicks T, Burnstein M, Dentsman F, Fazio V, Glennon E, Hyman N, Kerner B, Kilkenny J, Moore R, Peters W, Ross T, Savoca P, Vernava A, Wong WD. Practice parameters for detection of colorectal neoplasms. The Standards Committee, The American Society of Colon and Rectal Surgeons. Dis Colon Rectum. 1999;42(9):1123-9.
14) NCI: PDQ (Physician Data Query); Colorectal cancer screening  http://www.cancer.gov/cancertopics/pdq/screening/colorectal/healthprofessional
15) 経口腸管洗浄剤「ニフレック」等による腸管穿孔及び腸閉塞に関する緊急安全性情報の発出について. 2003. http://www.mhlw.go.jp/houdou/2003/09/h0910-1.html.
16) 大腸検査前処置用下剤テクトロール散 安全性情報. 2003.
http://www.kaigen.co.jp/pdf/topix2.pdf.
17) Mandel JS, Church TR, Ederer F, Bond JH. Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood. J Natl Cancer Inst 1999;91(5):434-7.
18) Scholefield JH, Moss S, Sufi F, Mangham CM, Hardcastle JD. Effect of faecal occult blood screening on mortality from colorectal cancer: results from a randomized controlled trial. Gut 2002;50:840-4.
19) Jorgensen OD, Kronborg O, Fenger C. A randomized study of screening for colorectal cancer using faecal occult blood testing: results after 13 years and seven biennial screening rounds. Gut 2002;50:29-32.
20) Towler B, Irwig L, Glasziou P, Kewenter J, Weller D, Silagy C. A systematic review of the effects of screening for colorectal cancer using the faecal occult blood test, hemoccult. BMJ 1998;317:559-65.
21) Newcomb PA, Norfleet RG, Storer BE, Surawicz TS, Marcus PM. Screening sigmoidoscopy and colorectal cancer mortality. J Natl Cancer Inst 1992;84:1572-5. 化学法 S状結腸鏡 直腸指診
22) Selby JV, Friedman GD, Quesenberry CP Jr, Weiss NS. Effect of fecal occult blood testing on mortality from colorectal cancer. A case-control study. Ann Intern Med 1993;118:1-6.
23) Wahrendorf J, Robra BP, Wiebelt H, Oberhansen R, Weiland M, Dhom G. Effectiveness of colorectal cancer screening: results from a population-based case-control evaluation in Saarland, Germany. Eur J Cancer Prev 1993;2:221-7.
24) Lazovich D, Weiss NS, Stevens NG, White E, McKnight B, Wagner EH. A case-control study to evaluate efficacy of screening for faecal occult blood. J Med Screen 1995;2:84-9.
25) Zappa M, Castiglione G, Grazzini G, Falini P, Giorgi D, Paci E, Ciatto S. Effect faecal occult blood testing on colorectal mortality: results of a population-based case-control study in the district of Florence, Italy. Int J Cancer 1997;73:208-10. 化学法 免疫法
26) Bertario L, Russo A, Crosignani P, Sala P, Spinelli P, Pizzetti P, Andreola S, Berrino F. Reducing colorectal cancer mortality by repeated faecal occult blood test: a nested case-control study. Eur J Cancer 1999;35(6):973-7.
27) Faivre J, Tazi MA, El Mrini T, Lejeune C, Benhamiche AM, Dassonville F. Faecal occult blood screening and reduction of colorectal cancer mortality: a case-control study. Br J Cancer 1999;79:680-3.
28) Scheitel SM, Ahlquist DA, Wollan PC, Hagen PT, Silverstein MD. Colorectal Cancer Screening: a community case-control study of proctosigmoidoscopy, barium enema radiography, and fecal occult blood test efficacy. Mayo Clin Proc 1999;74:1207-13. 化学法 注腸X線検査
29) Winawer SJ, Flehinger BJ, Schottenfeld D, Miller DG. Screening for colorectal cancer with fecal occult blood testing and sigmoidoscopy. J Natl Cancer Inst 1993;85(16):1311-8. 化学法 S状結腸鏡+化学法
30) Mandel JS, Church TR, Bond JH, Ederer F, Geisser MS, Mongin SJ, Snover DC, Schuman LM. The Effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med 2000;343(22):1603-7.
31) 熊西康信,藤田昌英,奥山也寸志,杉山龍平,太田 潤,田口鐵男,大島 明,津熊秀明,藤本伊三郎.大腸集検における便潜血検査の精度評価―制限食下シオノギB3枚法のがん登録との照合による分析―日消集検誌 1990;87:160-4.
32) Hisamichi S, Fukao A, Fujii Y, Tsuji I, Komatsu S, Inawashiro H, Tsubono Y. Mass screening for colorectal cancer in Japan. Cancer Detect Prev. 1991;15(5):351-6. 化学法 免疫法
33) Iwase T. The evaluation of an immunochemical occult blood test by reversed passive hemagglutination compared with Hemoccult II in screening for colorectal cancer. In: Fecal occult blood tests: Current issues and new tests. Young GP and Saito H eds. Smith Kline Diagnostics Inc. San Jose, 1992:90-5.
34) 村上良介,今西清,大谷透,中西克巳,筆本由幸,石川秀樹,日山與彦,津熊英明,三木信夫,大島 明.便潜血検査の食道,胃および大腸の各がんに対する診断精度.成人病. 1993;33:1-7.
35) Bang KM, Tillett S, Hoar SK, Blair A, McDougall V. Sensitivity of fecal hemoccult testing and flexible sigmoidoscopy for colorectal cancer screening. J Occup Med 1986;28:709-13.
36) Walter SD, Frommer DJ, Cook RJ. The estimation of sensitivity and specificity in colorectal cancer screening methods. Cancer Detect Prev.1991;15(6):465-9. 化学法 免疫法
37) Thomas WM, Pye G, Hardcastle JD, Walker AR. Screening for colorectal carcinoma: an analysis of the sensitivity of haemoccult. Br J Surg 1992;79(8):833-5.
38) Rozen P, Knaani J, Papo N. Evaluation and comparison of an immunochemical and a guaiac faecal occult blood screening test for colorectal neoplasia. Eur J Cancer Prev. 1995;4(6):475-81. 化学法 免疫法
39) Robinson MH, Kronborg O, Williams CB, Bostock K, Rooney PS, Hunt LM, Hardcastle JD. Faecal occult blood testing and colonoscopy in the surveillance of subjects at high risk of colorectal neoplasia. Br J Surg 1995;82:318-20. 化学法 免疫法
40) Allison JE, Tekawa IS, Ransom LJ, Adrain AL. A comparison of fecal occult-blood tests for colorectal-cancer screening. N Engl J Med 1996;334:155-9. 化学法 免疫法
41) Launoy G, Smith TC, Duffy SW, Bouvier V. Colorectal cancer mass-screening: estimation of fecal occult blood test sensitivity, taking into account cancer mean sojourn time. Int J Cancer 1997;73:220-4.
42) Tazi MA, Faivre J, Lejeune C, Bolard P, Phelip JM, Benhamiche AM. Interval cancers in a community-based programme of colorectal cancer screening with faecal occult blood test. Eur J Cancer Prev 1999;8:131-5.
43) Zappa M, Castiglione G, Paci E, Grazzini G, Rubeca T, Turco P, Crocetti E, Ciatto S. Measuring interval cancers in population-based screening using different assays of fecal occult blood testing: The District of Florence experience. Int J Cancer 2001;92:151-4.
44) Robinson MH, Hardcastle JD, Moss SM, Amar SS, Chamberlain JO, Armitage NC, Scholefield JH, Mangham CM. The risks of screening: data from the Nottingham randomized controlled trial of faecal occult blood screening for colorectal cancer. Gut 1999;45:588-92.
45) Jensen BM, Kronborg O, Fenger C. Interval cancers in screening with fecal occult blood test for colorectal cancer. Scand J Gastroenterol 1992;27(9):779-82.
46) Bouvier V, Herbert C, Lefevre H, Launoy G. Stage of extension and treatment for colorectal cancer after a negative test and among non-responders in mass screening with guaiac faecal occult blood test: a French experience. Eur J Cancer Prev 2001;10:323-6.
47) Hiwatashi N, Morimoto T, Fukao A, Sato H, Sugahara N, Hisamichi S, Toyota T. An evaluation of mass screening using fecal occult blood test for colorectal cancer in Japan: a case-control study. Jpn J Cancer Res. 1993;84:1110-2.
48) Saito H, Soma Y, Koeda J, Wada T, Kawaguchi H, Sobue T, Aisawa T, Yoshida Y. Reduction in risk of mortality from colorectal cancer by fecal occult blood screening with immunochemical hemagglutination test. A case-control study. Int J Cancer. 1995;61:465-9.
49) Saito H, Soma Y, Nakajima M, Koeda J, Kawaguchi H, Kakizaki R, Chiba R, Aisawa T, Munakata A. A case-control study evaluating occult blood screening for colorectal cancer with hemoccult test and an immunochemical hemagglutination test. Oncol Rep. 2000;7:815-9.
50) 黒石哲生,広瀬かおる,鈴木隆一郎,富永祐民.検診カバー率と大腸がん死亡率の推移からみた大腸がん検診の評価.日消集検誌. 1999;37(1):71-5.
51) 村上良介,今西 清,大谷 透,中西克己,石川秀樹,日山與彦,津熊秀明,藤本伊三郎,三木信夫, 大島 明.大腸がん検診発見がんの特徴および本検診の精度.日消集検誌. 1992;94:63-8.
52) 藤田昌英,奥山也寸志,村上良介,仲尾美穂,花井 彩,阪本康夫,楠山剛紹,高井新一郎.大腸集検における複数回免疫便潜血検査(RPHA)によるスクリーニングの精度評価.日消集検誌. 1995;33(4):477-85.
53) Nakama H, Yamamoto M, Kamijo N, Li T, Wei N, Fattah AS, Zhang B. Colonoscopic evaluation of immunochemical fecal occult blood test for detection of colorectal neoplasia. Hepatogastroenterology. 1999;46:228-31.
54) 松田一夫,山崎 信.大腸集検における中間期癌;福井県がん登録との記録照合による検討. 日消集検誌. 1998;36(1):45-50.
55) Wada T, Saito H, Soma Y, Koeda J, Kawaguchi H, Tanaka M, Yoshida Y, Munakata A. Survival for patients with colorectal cancer detected by population-based screening program using an immunochemical fecal occult blood test. Int J Oncology. 1996;9:685-91.
56) 松田一夫,渡辺国重.大腸がん検診における予後不良例;大腸癌の発見経緯からみた検討.日消集検誌. 2001;39(4):289-97.
57) Nakajima M, Saito H, Soma Y, Sobue T, Tanaka M, Munakata A. Prevention of advanced colorectal cancer by screening using the immunochemical fecal occult blood test: a case-control study. Br J Cancer. 2003;89:23-8.
58) Selby JV, Friedman GD, Quesenberry CP Jr, Weiss NS. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med. 1992;326:653-7.
59) Muller AD, Sonnenberg A. Protection by endoscopy against death from colorectal cancer A case-control study among veterans. Arch Intern Med. 1995;155:1741-8. S状結腸鏡 全大腸内視鏡
60) Kavanagh AM, Giovannucci EL, Fuchs CS, Colditz GA. Screening endoscopy and risk of colorectal cancer in United States men. Cancer Causes Control. 1998;9:455-62. S状結腸鏡 全大腸内視鏡
61) Thiis-Evensen E, Hoff GS, Sauar J, Langmark F, Majak BM, Vatn MH. Population-based surveillance by colonoscopy: effect on the incidence of colorectal cancer. Telemark Polyp Study I. Scand J Gastroenterol. 1999;34(4):414-20. S状結腸鏡 全大腸内視鏡
62) 藤好建史,富岡一美,松尾雄三,四元純正,小西忠光,若田真由美,古賀厚子,高本潤子. 大腸がん検診における見逃し率.日本医事新報. 1993;3624:43-5.
63) 森元富造,樋渡信夫,島田剛延,佐藤弘房,池田卓,豊田隆謙.大腸がん検診における精密検査の診断精度.日消集検誌. 1996;34(4):451-5.
64) Kewenter J, Brevinge H, Engaras B, Haglind E. The yield of flexible sigmoidoscopy and double-contrast barium enema in the diagnosis of neoplasms in the large bowel in patients with a positive Hemoccult test. Endoscopy. 1995;27:159-63. S状結腸鏡 注腸X線検査
65) Lieberman DA, Weiss DG, Bond JH, Ahnen DJ, Garewal H, Chejfec G. Use of colonoscopy to screen asymptomatic adults for colorectal cancer. Veterans Affairs Cooperative Study Group 380. N Engl J Med. 2000;343:162-8. S状結腸鏡 全大腸内視鏡
66) Yoshinaga M, Watabe R, Takeda H, Yanagisawa J, Higuchi K, Tsuda Y, Harada N, Nawata H, Ikeda K. Subjects older than 60 years with negative findings on sigmoidoscopy should still undergo colonoscopy. Hepatogastroenterology. 2002;49(45):668-71.
67) Atkin WS, Hart A, Edwards R, McIntyre P, Aubrey R, Wardle J, Sutton S, Cuzick J, Northover JM. Uptake, yield of neoplasia, and adverse effects of flexible sigmoidoscopy screening. Gut. 1998;42:560-5.
68) Verne JE, Aubrey R, Love SB, Talbot IC, Northover JM. Population based randomized study of uptake and yield of screening by flexible sigmoidoscopy compared with screening by faecal occult blood testing. BMJ. 1998; 317:182-5.
69) Kewenter J, Brevinge H. Endoscopic and surgical complications of work-up in screening for colorectal cancer. Dis Colon Rectum. 1996;39(6):676-80.
70) Anderson ML, Pasha TM, Leighton JA. Endoscopic perforation of the colon: lessons from a 10-year study. Am J Gastroenterol. 2000;95(12):3418-22.
71) 野崎良一,田中長利,多田隈奈津子,守田則一,高野正博. IFOBT以外の大腸癌一次スクリーニング法:便潜血検査とシグモイドスコピーを併用した大腸がんスクリーニング.早期大腸癌. 2001;5(2):179-84.
72) 楠山剛紹,樋渡信夫,斎藤 博,村上良介,松田一夫,有末太郎,相馬 悌,小枝淳一,工藤進英,後藤英世,望月福治,井上 隆,岩瀬孝明,鈴木康元,大谷透,藤田昌英,吉原正治,日高久光.大腸精密検査の精度および偶発症に関する検討−施設共同研究− 厚生省がん研究補助金による大腸がん集団検診の精度向上と評価に関する研究平成8年度研究報告. 1997.3;12-20.
73) 日本消化器内視鏡学会消毒委員会.日本消化器内視鏡学会消毒委員会アンケート調査報告書.日本消化器内視鏡学会誌. 1999;41(2):215-9.
74) Demers RY, Parsons KC. Colorectal cancer incidence in pattern and model makers:evidence from a screening program. Am J Ind Med. 1994;26:33-45.
75) Lieberman DA, Weiss DG, et al. One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon. N Engl J Med. 2001;345(8):555-60.
76) Sung JJ, Chan FK, Leung WK, Wu JC, Lau JY, Ching J, To KF, Lee YT, Luk YW, Kung NN, Kwok SP, Li MK, Chung SC. Screening for colorectal cancer in Chinese: comparison of fecal occult blood test, flexible sigmoidoscopy, and colonoscopy. Gastroenterology. 2003;124:608-14.
77) Niv Y, Dickman R, Figer A, Abuksis G, Fraser G. Case-control study of screening colonoscopy in relatives of patients with colorectal cancer. Am J Gastroenterol. 2003;98(2):486-9. 全大腸内視鏡 注腸X線検査
78) Rex DK, Rahmani EY, Haseman JH, Lemmel GT, Kaster S, Buckley JS. Relative sensitivity of colonoscopy and barium enema for detection of colorectal cancer in clinical practice. Gastroenterology. 1997;112:17-23. 全大腸内視鏡 注腸X線検査
79) Smith GA, O' Dwyer PJ. Sensitivity of double contrast barium enema and colonoscopy for the detection of colorectal neoplasms. Surg Endosc. 2001;15:649-52. 全大腸内視鏡 注腸X線検査
80) Imperiale TF, Wagner DR, Lin CY, Larkin GN, Rogge JD, Ransohoff DF. Risk of advanced proximal neoplasms in asymptomatic adults according to the distal colorectal findings. N Engl J Med. 2000;343:169-74.
81) Winawer SJ, Zauber AG, Ho MN, O' Brien MJ, Gottlieb LS, Sternberg SS, Waye JD, Schapiro M, Bond JH, Panish JF, Ackroyd F, Shike M, Kurtz RC, Hornsby-Lewis L, Gerdes H, Stewart ET. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med. 1993;329(27):1977-81.
82) Citarda F, Tomaselli G, Capocaccia R, Barcherini S, Crespi M, et al. Efficacy in standard clinical practice of colonoscopic polypectomy in reducing colorectal cancer incidence. Gut. 2001;48:812-5.
83) 村上良介,今西清,大谷 透,中西克己,石川秀樹,津熊秀明,藤本伊三郎,三木信夫,大島 明,山本明弘,吉川宣輝,熊西康信,藤田昌英,田口鐵男.大腸ポリープの自然史に関する臨床疫学的研究;内視鏡的ポリープ摘除術の大腸がん予防効果.成人病. 1991;31:49-55.
84) 金子榮蔵,原田英雄,春日井達造,小越和栄,丹羽寛文.消化器内視鏡関連の偶発症に関する第4回全国調査報告―1988年より2002年までの5年間.日本消化器内視鏡学会誌. 2004;46(1):54-61.
85) Ott DJ, Scharling ES, Chen YM, Wu WC, Gelfand DW. Barium enema examination: sensitivity in detecting colonic polyps and carcinomas. South Med J. 1989;82(2):197-200.
86) Steine S, Stordahl A, Lunde OC, Loken K, Laerum E. Double-contrast barium enema versus colonoscopy in the diagnosis of neoplastic disorders: aspects of decision-making in general practice. Fam Pract. 1993;10(3):288-91.
87) 光島 徹,横田敏弘,永谷京平,横内敬二,阿部陽介,藤田隆三.大腸集検の精密検査法として妥当な方法は何か?;注腸X線検査と全大腸内視鏡検査における精度と施行特性の比較検討.日消集検誌.1990;87:65-73.
88) 松田一夫,武田孝之.福井県における大腸集検後の精検法の推移と精検偽陰性例の検討.日消集検誌. 1998;36(3):227-32.
89) Winawer SJ, Stewart ET, Zauber AG, Bond JH, Ansel H, Waye JD, Hall D, Hamlin JA, Schapiro M, O' Brien MJ, Sternberg SS, Gottlieb LS. A comparison of colonoscopy and double-contrast barium enema for surveillance after polypectomy. National Polyp Study Work Group. N Engl J Med 2000;342(24):1766-72.
90) Brady AP, Stevenson GW, Stevenson I. Colorectal cancer overlooked at barium enema examination and colonoscopy: a continuing perceptual problem. Radiology. 1994;192(2):373-8.
91) Blakeborough A, Sheridan MB, Chapman AH. Complications of barium enema examinations: a survey of UK Consultant Radiologists 1992 to 1994. Clin Radiol. 1997;52:142-8.
92) 丸山隆司,岩井一男,西沢かな枝,野田豊,隈本芳一. X線診断による臓器・組織線量・実効線量及び集団実効線量.RADIOISOTOPES. 1996;145:761-73.
93) Herrinton LJ, Selby JV, Friedman GD, Quesenberry CP, Weiss NS. Case-control study of digital-rectal screening in relation to mortality from cancer of the distal rectum. Am J Epidemiol. 1995;142(9):961-4.
94) Canadian Task Force on Preventive Health Care. Colorectal cancer screening. Recommendation statement from the Canadian Task Force on Preventive Health Care. CMAJ; 2001;165(2):206-8.
95) Finnish Medical Society Duodecim. Prevention and screening of colorectal cancer.Helsinki, Finland: Duodecim Medical Publication Ltd; 2002.
96) Miles A, Cockburn J, Smith RA, Wardle J. A perspective from countries using organized screening programs. Cancer 2004;101(5 Suppl):1201-13.
97) Tsuji I, Fukao A, Sugawara N, Shoji T, Kuwajima I, Hisamichi S. Cost-effectiveness analysis of screening for gastric cancer in Japan. Tohoku J. Exp. Med. 1991;164(4):279-84.
98) Shimbo T, Glick HA, Eisenberg JM. Cost-effectiveness analysis of strategies for colorectal cancer screening in Japan. Int J Technol Assess Health Care. 1994;10(3):359-75.
99) Mant D, Fuller A, Northover J, Astrop P, Chivers A, Crockett A, Clements S, Lawrence M. Patient compliance with colorectal cancer screening in general practice. Br J Gen Pract. 1992;42(354):18-20.
100) Myers RE, Ross EA, Wolf TA, Balshem A, Jepson C, Millner L. Behavioral interventions to increase adherence in colorectal cancer screening. Med Care. 1991;29(10):1039-50.
101) Lee CY. A randomized controlled trial to motivate worksite fecal occult blood testing. Yonsei Med J. 1991;32(2):131-8.
102) Thompson RS, Michnich ME, Gray J, Friedlander L, Gilson B. Maximizing compliance with hemoccult screening for colon cancer in clinical practice. Med Care. 1986;24(10):904-14.
103) Weinrich SP, Weinrich MC, Stromborg MF, Boyd MD, Weiss HL. Using elderly educators to increase colorectal cancer screening. Gerontologist. 1993;33(4):491-6.
104) Hart AR, Barone TL, Gay SP, Inglis A, Griffin L, Tallon CA, Mayberry JF. The effect on compliance of a health education leaflet in colorectal cancer screening in general practice in central England. J Epidemiol Community Health. 1997.51(2);187-91.
105) Tilley BC, Vernon SW, Myers R, Glanz K, Lu M, Hirst K, Kristal AR. The Next Step Trial: impact of a worksite colorectal cancer screening promotion program. Prev Med. 1999;28(3):276-83.
106) Hart AR, Eaden J, Barnett S, de Bono AM, Mayberry JF. Colorectal cancer prevention. An approach to increasing compliance in a faecal occult blood test screening programme. J Epidemiol Community Health. 1998;52(12):818-20.
107) Pignone M, Harris R, Kinsinger L. Videotape-based decision aid for colon cancer screening. A randomized, controlled trial. Ann Intern Med. 2000;133(10):761-9.
108) Friedman LC, Everett TE, Peterson L, Ogbonnaya KI, Mendizabal V. Compliance with fecal occult blood test screening among low-income medical outpatients: a randomized controlled trial using a videotaped intervention. J Cancer Educ. 2001;16(2):85-8.
109) Vinker S, Nakar S, Rosenberg E, Kitai E. The role of family physicians in increasing annual fecal occult blood test screening coverage: a prospective intervention study. Isr Med Assoc J. 2002;4(6):424-5.
110) Tazi MA, Faivre J, Dassonville F, Lamour J, Milan C, Durand G. Participation in faecal occult blood screening for colorectal cancer in a well defined French population: results of five screening rounds from 1988 to 1996. J Med Screen. 1997;4(3):147-51.
111) Wardle J, Williamson S, McCaffery K, Sutton S, Taylor T, Edwards R, Atkin W. Increasing attendance at colorectal cancer screening: testing the efficacy of a mailed, psychoeducational intervention in a community sample of older adults. Health Psychology. 2003;22(1):99-105.
112) 日本消化器内視鏡学会監修.消化器内視鏡ガイドライン第2版.1999.医学書院.東京.
113) Sheridan SL, Harris RP, Woolf SH, et al. Shared decision making about screening and chemoprevention. a suggested approach from the U.S. Preventive Services Task Force. Am J Prev Med. 2004;26(1):56-66.
114) Briss P, Rimer B, Reilley B, Coates RC, Lee NC, Mullen P, Corso P, Hutchinson AB Hiatt R, Kerner J, George P, White C, Gandhi N, Saraiya M, Breslow R, Isham G, Teutsch SM, Hinman AR, Lawrence R, et al. Promoting informed decisions about cancer screening in communities and healthcare systems. Am J Prev Med. 2004;26(1):67-8
115) 厚生労働省大臣官房統計情報部編.平成14年度地域保健・老人保健事業報告(老人保健編).2003.厚生統計協会.東京.
116) 日本消化器集団検診学会全国集計委員会.平成14年消化器集団検診学会報告.日消集検誌. 2005;43(1):54-73.

 

書誌情報